2017
DOI: 10.1002/cjp2.84
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of commercially available Zika virus antibodies for use in a laboratory‐developed immunohistochemical assay

Abstract: Zika virus (ZIKV) infection during pregnancy can cause adverse fetal outcomes and severe irreversible congenital birth defects including microcephaly. Immunohistochemistry (IHC) is a valuable diagnostic tool for detecting ZIKV antigens in tissues from cases of fetal loss in women infected with ZIKV, and for providing insights into disease pathogenesis. As a result, there is increasing demand for commercially available ZIKV antibodies for use in IHC assays. ZIKV antibodies were selected and obtained from commer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
13
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(15 citation statements)
references
References 23 publications
2
13
0
Order By: Relevance
“…Also, the capability of this strain to infect fetus passing placental barrier is unknown and might be lower than the capability of the Asian lineage to cause fetal infection. The labeling observed was consistent to previously described ZIKV IHC regarding location and shape 21 , the antibody utilized targets ZIKV NS1. NS1 detection in serum is a diagnostic marker of Flavivirus infection 22 , this protein is involved in immune evasion and pathogenicity, and the antibody used in this study presents no cross reactivity with other flaviviruses 21 .…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…Also, the capability of this strain to infect fetus passing placental barrier is unknown and might be lower than the capability of the Asian lineage to cause fetal infection. The labeling observed was consistent to previously described ZIKV IHC regarding location and shape 21 , the antibody utilized targets ZIKV NS1. NS1 detection in serum is a diagnostic marker of Flavivirus infection 22 , this protein is involved in immune evasion and pathogenicity, and the antibody used in this study presents no cross reactivity with other flaviviruses 21 .…”
Section: Discussionsupporting
confidence: 88%
“…The labeling observed was consistent to previously described ZIKV IHC regarding location and shape 21 , the antibody utilized targets ZIKV NS1. NS1 detection in serum is a diagnostic marker of Flavivirus infection 22 , this protein is involved in immune evasion and pathogenicity, and the antibody used in this study presents no cross reactivity with other flaviviruses 21 . NS5 fragment sequencing revealed 3 mutations of which, 2 were located in the MTase coding region and 1 was in the RdRP coding region.…”
Section: Discussionsupporting
confidence: 88%
“…Paraffin-embedded tissue samples were processed for histopathology and stained with hematoxylin and eosin (HE). For immunohistochemistry (IHC), an adapted Streptavidin Alkaline Phosphatase (SAAP) assay [8,13,14,15,16,17,18] with anti-ZIKV polyclonal mouse antibody. The polyclonal anti-ZIKV antibody used in the IHC assay was prepared at the Instituto Evandro Chagas (IEC, Ananindeua, Brazil) in young Swiss mice using a ZIKV strain isolated in cell culture (C6/36 cells).…”
Section: Methodsmentioning
confidence: 99%
“…Tetramethylbenzidine (TMBZ) was purchased from Dojindo (Kumamoto, Japan). Anti-ZIKV NS1 protein antibody was purchased from Gene Tex Inc. (Irvine, CA, USA), which does not react with any other type of flavivirus group of the NS1 protein [20]. Zika virus recombinant NS1 antigen was purchased from the Native Antigen (Oxford, UK).…”
Section: Methodsmentioning
confidence: 99%